Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry. - Wikidata - awgldk - TriplyDB

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

http://www.wikidata.org/entity/Q34289134

about

Clinical usefulness of mepolizumab in severe eosinophilic asthma Emerging therapies for severe asthma Asthma is Different in Women Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability.Computational modeling of the obstructive lung diseases asthma and COPD.Temperature-controlled laminar airflow in severe asthma for exacerbation reduction (The LASER Trial): study protocol for a randomised controlled trial.Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.Omalizumab: clinical use for the management of asthma.Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry.Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic.The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children Inhaled and systemic corticosteroid response in severe asthma assessed by alveolar nitric oxide: a randomized crossover pilot study of add-on therapy.The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Hypoxia potentiates allergen induction of HIF-1α, chemokines, airway inflammation, TGF-β1, and airway remodeling in a mouse model Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment.Is allergic sensitization relevant in severe asthma? Which allergens may be culprit?Exacerbations of severe asthma.The investigation of severe asthma to define phenotypes.Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm.Diagnosis and investigation in the severe asthma clinic.Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Case series: the application of "third wave" cognitive behavioural therapies in difficult to treat asthma.Procedural and short-term safety of bronchial thermoplasty in clinical practice: evidence from a national registry and Hospital Episode Statistics.Co-morbidities in severe asthma: Clinical impact and management.Burden of systemic glucocorticoid-related complications in severe asthma.Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.Multi-scale computational models of the airways to unravel the pathophysiological mechanisms in asthma and chronic obstructive pulmonary disease (AirPROM).The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma.The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma.A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.RItA: The Italian severe/uncontrolled asthma registry.Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis.Case reports - When bronchial obstruction in the young adult is not asthma and inhalers do not help.Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma.Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR)

P2860

Q26746215-89B26E31-1FE3-47B9-8419-00D4C6EA3550 Q26861260-38696392-8FA5-4FDF-9636-EBCCB7DE2EE3 Q28388843-C6634C4C-CED9-4BED-B72C-C440DC729108 Q30620652-1BFAAA8C-6340-444F-8C90-E16D2F47E37A Q33945875-BF3A3504-CAA2-46B1-9BD5-237E60F2072A Q34632263-89CC34CD-31B5-47AF-BFB0-5239E004124F Q35888513-7678E76E-25A7-4FB5-BF73-5AFFCAEECB4D Q35906666-F4657552-2278-49C0-A5FF-81583650463B Q36055963-9845BCDE-ED44-40C9-8BF6-95777E4994C4 Q36110425-8EED04D8-71D3-4216-BB26-7BFF7351D4CA Q36194527-00742C6A-3A2A-4862-9495-0643833AD06B Q36422663-A307EE2D-218F-4DFA-A690-83ECF9082D62 Q36562454-E00E674D-D416-45FF-8B01-545DEEBE9424 Q36566081-C2D375F9-5921-4784-B8A3-BB2FBB8E30AE Q37265367-AD55F891-041D-4244-88D9-C8495880C221 Q37384805-0F951E02-1A15-4704-A206-7DDAD2C5FE18 Q37569401-ABE339B4-D138-40EE-BB1D-DC6289B5E02B Q38003660-6EF469A9-0C2C-49DD-9DA1-C69131C8645B Q38003661-57A51CC3-B730-4C43-96CE-1E81FCC308FB Q38118606-8E7B87BE-86F1-4095-B3DD-CA52CFD7D64A Q38770013-DA798BBC-7440-40B0-8FE1-C7B423C98343 Q38790815-60D26928-57CB-42B1-B285-752F4FD28B9C Q39001802-39892B15-BCF5-4AF0-9DEC-5244747849C5 Q39140071-17973266-C45A-46EE-B34F-D4B0619E2E8F Q39192970-E919A6F2-E349-4166-9D7C-E1789A4A8A13 Q39391610-49006AE9-1400-45D7-8BAC-99D3F28BEA6F Q39650450-842D3154-557F-4E0A-A640-8E17DC60CE74 Q40185991-C81C2E46-378C-4FDE-97AD-B2FAE3A3C4D8 Q42318567-3F1AD72D-9AAB-4353-A447-4D921D2CDD59 Q45846048-BB936E8C-811E-448F-A9DD-17587CA2F5A6 Q47568455-4F56125E-4242-4873-85F3-121679325A89 Q47598081-323B97A7-7733-495B-BC86-6AC3A0B67F32 Q47691413-337A390F-C2A3-4023-A2DF-759C5AE22296 Q47769040-E823C69E-6325-4536-95CF-34065E6BE7B0 Q50550361-B5C2628C-07D6-45E7-A4FE-24542AB9A823 Q53248436-5F467DD4-B867-4A7F-9651-A6DB41681834 Q58769009-D2E8D908-637E-4D89-826F-EEB5B30F104A

P2860

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

http://www.wikidata.org/entity/Q34289134

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@ast

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@en

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@nl

type

label

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@ast

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@en

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@nl

prefLabel

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@ast

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@en

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@nl

P1433

Q34289134-0BDA1B71-42F4-48CD-B322-D0B003D3AF09

P1476

Q34289134-BC4A0836-8A00-4E38-BB15-CCC40BCB40D5

P2093

Q34289134-0E02EAC7-CF2C-4D4E-82B4-95B7DACC7F76

Q34289134-48141D8F-9713-4403-BE65-E18003EF1420

Q34289134-4CE2691B-2FCE-47BA-BE45-B369B692F0D5

Q34289134-5AC8C7F9-69E6-4785-9EFB-0875061F01A7

Q34289134-917A7991-7A68-497B-9354-849876C546EB

Q34289134-A4D7A942-5E7F-4453-9551-997F7DB74882

P2860

Q34289134-032C06E7-7FEF-46A3-A413-749355B907C9

Q34289134-1363C172-FFB7-4DB3-B5B1-D2E3D58096E3

Q34289134-15013ADE-2512-4DAD-8109-C5035E50F09D

Q34289134-6478D389-5FCC-477B-8DA2-E24C6C9ACB7D

Q34289134-6E505554-B36E-4A17-90FC-37FB7069EDCD

Q34289134-7DD5541C-D1DB-438A-BA64-D085818BC446

Q34289134-7FA62645-F631-433B-A124-3A4277059445

Q34289134-B460A7C4-3C38-4819-AC6A-EF90002BE230

Q34289134-CCEECB21-742D-4382-BDEB-1B529092DFF6

Q34289134-CF91CA4D-C71E-4F6D-80DD-C3DD018D2FD2

P304

Q34289134-CF0B944A-AC89-4CF2-B85E-5B3D9C75527F

P31

Q34289134-91698B98-C94C-4D96-8324-14CD91E2D673

P356

Q34289134-C7A4A041-30C5-4A84-B2A6-CAC4A6DD73BC

P407

Q34289134-A376C317-3923-4F7C-A225-DF61659C827B

P433

Q34289134-B55AE472-9EB7-4ECD-9596-A73EC944D89E

P478

Q34289134-9B993C84-8A28-4719-8C9F-E736C1C267CA

P577

Q34289134-95BD0900-7886-486B-AF51-B0A708DF9257

P5875

Q34289134-FBC13EC3-3922-4DB3-91C1-6393628ACD89

P698

Q34289134-43B1F439-7ADE-4772-AF94-81DB96B05C85

P921

Q34289134-57B9AD63-6595-43B6-BB99-FEA848E43929

Q34289134-9B11D668-277B-44B0-8DF4-980969D5E505

P932

Q34289134-C08998BB-4797-492C-88A3-BCA9A0291F0E

P356

THX.2010.137414

P1433

P1476

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.

@en

P2093

Andrew Menzies-Gow

http://www.w3.org/2001/XMLSchema#string

British Thoracic Society Difficult Asthma Network

http://www.w3.org/2001/XMLSchema#string

Chris E Brightling

http://www.w3.org/2001/XMLSchema#string

Liam G Heaney

http://www.w3.org/2001/XMLSchema#string

Michael Stevenson

http://www.w3.org/2001/XMLSchema#string

Rob M Niven

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma.

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

A case-control study of deaths from asthma.

Predictors of loss of asthma control induced by corticosteroid withdrawal

A national estimate of the economic costs of asthma.

The costs of asthma.

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Systematic assessment of difficult-to-treat asthma.

Severe asthma in adults: what are the important questions?

P304

787-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2010.137414

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46095124

http://www.w3.org/2001/XMLSchema#string

P698

20805172

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2975949

http://www.w3.org/2001/XMLSchema#string